Loading...
Header Logo
Keywords
Last Name
Institution

Rong Shao Ph.D. M.D.

TitleResearch Assistant Professor
InstitutionUniversity of Massachusetts Amherst
DepartmentCollege of Natural Sciences
Address431 Integrated Science Center
Amherst, MA 01003
Phone413-545-2312
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Yao H, Sun L, Li J, Zhou X, Li R, Shao R, Zhang Y, Li L. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells. Int J Nanomedicine. 2020; 15:7013-7034. PMID: 33061365.
      View in: PubMed
    2. Sheel A, Shao R, Brown C, Johnson J, Hamilton A, Sun D, Oppenheimer J, Smith W, Visconti PE, Markstein M, Bigelow C, Schwartz LM. Acheron/Larp6 Is a Survival Protein That Protects Skeletal Muscle From Programmed Cell Death During Development. Front Cell Dev Biol. 2020; 8:622. PMID: 32850788.
      View in: PubMed
    3. Gong J, Zheng Y, Wang Y, Sheng W, Li Y, Liu X, Si S, Shao R, Zhen Y. A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway. PLoS One. 2018; 13(2):e0191984. PMID: 29394294.
      View in: PubMed
    4. Liu H, Ma Y, He HW, Zhao WL, Shao RG. SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells. Autophagy. 2017 May 04; 13(5):900-913. PMID: 28521610.
      View in: PubMed
    5. Sha MQ, Zhao XL, Li L, Li LH, Li Y, Dong TG, Niu WX, Jia LJ, Shao RG, Zhen YS, Wang Z. EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells. Cell Death Dis. 2016 11 24; 7(11):e2486. PMID: 27882937.
      View in: PubMed
    6. Shao R, Taylor SL, Oh DS, Schwartz LM. Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget. 2015 Dec 01; 6(38):40507-18. PMID: 26439689.
      View in: PubMed
    7. Zhao W, Jiang G, Bi C, Li Y, Liu J, Ye C, He H, Li L, Song D, Shao R. The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2a by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation. Oncotarget. 2015 Nov 10; 6(35):37871-94. PMID: 26462155.
      View in: PubMed
    8. Zhang H, Ma Y, Zhang S, Liu H, He H, Li N, Gong Y, Zhao S, Jiang JD, Shao RG. Involvement of Ras GTPase-activating protein SH3 domain-binding protein 1 in the epithelial-to-mesenchymal transition-induced metastasis of breast cancer cells via the Smad signaling pathway. Oncotarget. 2015 Jul 10; 6(19):17039-53. PMID: 25962958.
      View in: PubMed
    9. Sun YR, Zhang SH, Shao RG, He HW. [The synergistic effect of lidamycin and rituximab on human B cell lymphoma]. Yao Xue Xue Bao. 2014 Feb; 49(2):198-203. PMID: 24761609.
      View in: PubMed
    10. Zhang CX, He HW, Shao RG. [Sphingosine kinase 1 and tumor]. Yao Xue Xue Bao. 2013 Jul; 48(7):971-8. PMID: 24133963.
      View in: PubMed
    11. Shao R. YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front Physiol. 2013; 4:122. PMID: 23755018.
      View in: PubMed
    12. Scully S, Francescone R, Faibish M, Bentley B, Taylor SL, Oh D, Schapiro R, Moral L, Yan W, Shao R. Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J Neurosci. 2012 Sep 12; 32(37):12950-60. PMID: 22973019.
      View in: PubMed
    13. Zhang H, Zhang S, He H, Zhao W, Chen J, Shao RG. GAP161 targets and downregulates G3BP to suppress cell growth and potentiate cisplaitin-mediated cytotoxicity to colon carcinoma HCT116 cells. Cancer Sci. 2012 Oct; 103(10):1848-56. PMID: 22703643.
      View in: PubMed
    14. Francescone R, Scully S, Bentley B, Yan W, Taylor SL, Oh D, Moral L, Shao R. Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation. J Biol Chem. 2012 Jul 13; 287(29):24821-31. PMID: 22654102.
      View in: PubMed
    15. Scully S, Yan W, Bentley B, Cao QJ, Shao R. Inhibitory activity of YKL-40 in mammary epithelial cell differentiation and polarization induced by lactogenic hormones: a role in mammary tissue involution. PLoS One. 2011; 6(10):e25819. PMID: 21991364.
      View in: PubMed
    16. Shao R, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W. Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers. Br J Cancer. 2011 Oct 11; 105(8):1203-9. PMID: 21934681.
      View in: PubMed
    17. Francescone RA, Faibish M, Shao R. A Matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells. J Vis Exp. 2011 Sep 07; (55). PMID: 21931289.
      View in: PubMed
    18. Shao R, Scully SJ, Yan W, Bentley B, Mueller J, Brown C, Bigelow C, Schwartz LM. The novel lupus antigen related protein acheron enhances the development of human breast cancer. Int J Cancer. 2012 Feb 1; 130(3):544-54. PMID: 21387291.
      View in: PubMed
    19. Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem. 2011 Apr 29; 286(17):15332-43. PMID: 21385870.
      View in: PubMed
    20. Faibish M, Francescone R, Bentley B, Yan W, Shao R. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther. 2011 May; 10(5):742-51. PMID: 21357475.
      View in: PubMed
    21. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem. 2010 Apr 30; 285(18):14042-51. PMID: 20189993.
      View in: PubMed
    22. Shao R, Hamel K, Petersen L, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene. 2009 Dec 17; 28(50):4456-68. PMID: 19767768.
      View in: PubMed
    23. Li BW, Zhang M, He HW, Zhang SH, Shao RG. [Synergic effects of the combination of VEGF-targeted shRNA and taxol on human prostate cancer DU145 both in vitro and in vivo]. Yao Xue Xue Bao. 2009 Mar; 44(3):296-302. PMID: 19449527.
      View in: PubMed
    24. Ren K, Jin H, Bian C, He H, Liu X, Zhang S, Wang Y, Shao RG. MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway. J Biol Chem. 2008 Dec 19; 283(51):35598-605. PMID: 18948272.
      View in: PubMed
    25. Yan W, Bentley B, Shao R. Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis. Mol Biol Cell. 2008 May; 19(5):2278-88. PMID: 18353972.
      View in: PubMed
    26. Yan W, Shao R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem. 2006 Jul 14; 281(28):19700-8. PMID: 16702213.
      View in: PubMed
    27. Shao R, Guo X. Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochem Biophys Res Commun. 2004 Sep 3; 321(4):788-94. PMID: 15358096.
      View in: PubMed
    For assistance with using Profiles, please contact Profiles Support
    Shao's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (182) concept(s)
    _
    Co-Authors Expand Description
    See all (6) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _